Aimei Health Technology (AFJK) Competitors $11.29 +0.04 (+0.36%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AFJK vs. FVR, SJT, NREF, SBXD, CEPO, CEP, PLMK, FRGE, NETD, and OACCShould you be buying Aimei Health Technology stock or one of its competitors? The main competitors of Aimei Health Technology include FrontView REIT (FVR), San Juan Basin Royalty Trust (SJT), NexPoint Real Estate Finance (NREF), SilverBox Corp IV (SBXD), Cantor Equity Partners (CEPO), Cantor Equity Partners (CEP), Plum Acquisition Corp. IV (PLMK), Forge Global (FRGE), Nabors Energy Transition Corp. II (NETD), and Oaktree Acquisition Corp. III Life Sciences (OACC). These companies are all part of the "trading" industry. Aimei Health Technology vs. Its Competitors FrontView REIT San Juan Basin Royalty Trust NexPoint Real Estate Finance SilverBox Corp IV Cantor Equity Partners Cantor Equity Partners Plum Acquisition Corp. IV Forge Global Nabors Energy Transition Corp. II Oaktree Acquisition Corp. III Life Sciences Aimei Health Technology (NASDAQ:AFJK) and FrontView REIT (NYSE:FVR) are both small-cap trading companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation. Does the media prefer AFJK or FVR? In the previous week, FrontView REIT had 3 more articles in the media than Aimei Health Technology. MarketBeat recorded 4 mentions for FrontView REIT and 1 mentions for Aimei Health Technology. Aimei Health Technology's average media sentiment score of 1.89 beat FrontView REIT's score of 0.88 indicating that Aimei Health Technology is being referred to more favorably in the media. Company Overall Sentiment Aimei Health Technology Very Positive FrontView REIT Positive Do institutionals and insiders hold more shares of AFJK or FVR? 45.6% of Aimei Health Technology shares are held by institutional investors. 1.7% of Aimei Health Technology shares are held by insiders. Comparatively, 4.3% of FrontView REIT shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation & earnings, AFJK or FVR? Aimei Health Technology has higher earnings, but lower revenue than FrontView REIT. FrontView REIT is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAimei Health TechnologyN/AN/A$2.55M$0.2348.91FrontView REIT$66.68M4.20-$22.21M-$1.07-12.78 Do analysts recommend AFJK or FVR? FrontView REIT has a consensus target price of $15.10, suggesting a potential upside of 10.42%. Given FrontView REIT's stronger consensus rating and higher probable upside, analysts clearly believe FrontView REIT is more favorable than Aimei Health Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aimei Health Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FrontView REIT 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Is AFJK or FVR more profitable? Aimei Health Technology has a net margin of 0.00% compared to FrontView REIT's net margin of -43.21%. FrontView REIT's return on equity of -5.48% beat Aimei Health Technology's return on equity.Company Net Margins Return on Equity Return on Assets Aimei Health TechnologyN/A -95.88% 3.06% FrontView REIT -43.21%-5.48%-3.33% SummaryAimei Health Technology and FrontView REIT tied by winning 7 of the 14 factors compared between the two stocks. Get Aimei Health Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for AFJK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AFJK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFJK vs. The Competition Export to ExcelMetricAimei Health TechnologyUNCLASSIFIED IndustryFinancial SectorNASDAQ ExchangeMarket Cap$68.85M$169.73M$6.38B$10.27BDividend YieldN/AN/A4.31%4.60%P/E Ratio48.912.081,773.8226.41Price / SalesN/A32.501,352.5488.61Price / Cash39.9771.0348.9929.91Price / Book-70.3157.262.076.28Net Income$2.55M-$1.39M$1.23B$270.38M7 Day PerformanceN/A0.72%1.07%2.70%1 Month Performance0.72%1.14%1.78%5.99%1 Year Performance7.35%84.51%32.11%25.94% Aimei Health Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFJKAimei Health TechnologyN/A$11.25flatN/A+7.8%$68.85MN/A48.91N/APositive NewsFVRFrontView REIT2.2719 of 5 stars$13.58+1.3%$15.10+11.2%N/A$274.15M$66.68M-12.69N/ASJTSan Juan Basin Royalty Trust0.3957 of 5 stars$5.83-0.1%N/A+70.9%$271.73M$7.03M0.002,020Positive NewsNREFNexPoint Real Estate Finance3.7199 of 5 stars$15.15-0.9%$14.75-2.6%-4.7%$270.79M$72.51M6.291SBXDSilverBox Corp IVN/A$10.46-0.2%N/AN/A$266.26MN/A0.00N/ANews CoverageCEPOCantor Equity PartnersN/A$10.43flatN/AN/A$265.96MN/A0.002Positive NewsCEPCantor Equity PartnersN/A$19.75-0.3%N/A+110.6%$253.57MN/A0.00N/AGap UpPLMKPlum Acquisition Corp. IVN/A$10.28flatN/AN/A$249.22MN/A0.002Positive NewsFRGEForge Global3.6111 of 5 stars$17.05-4.7%$35.50+108.3%-17.4%$243.19M$79.33M-3.203Positive NewsNETDNabors Energy Transition Corp. II2.7869 of 5 stars$11.27-0.1%N/A+6.1%$240.83MN/A59.32N/APositive NewsShort Interest ↓OACCOaktree Acquisition Corp. III Life SciencesN/A$10.46+0.1%N/AN/A$234.57MN/A0.00N/ANews CoveragePositive News Related Companies and Tools Related Companies FVR Competitors SJT Competitors NREF Competitors SBXD Competitors CEPO Competitors CEP Competitors PLMK Competitors FRGE Competitors NETD Competitors OACC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFJK) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aimei Health Technology Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aimei Health Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
